Latest News
Long COVID has always been alarming, but there’s growing concern about its possible relationship to cancer. An expert at Yale’s School of Medicine explains the factors that could cause COVID to increase someone’s cancer risk.
- June 18, 2024Source: SolveCSF.org
Solve President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and Director of Advancement Ilise Friedman recently visited Yale School of Medicine’s Center for Infection & Immunity (CII), the Center Director, Sterling Professor Akiko Iwasaki, and her research team, as coordinated by Dr. Nicole Darricarrère, CII’s Scientific Program Director, in New Haven, CT. The Solve delegation honored Professor Iwasaki with an award to recognize her contributions to the study of infection-associated chronic conditions and illnesses, and delivered an invited talk to the Iwasaki Lab to elaborate the power of the Solve Together Real-World Platform to accelerate biomedical research for post-acute infection syndromes, such as ME/CFS and Long Covid.
- June 14, 2024
The Yale PAX LC Trial’s decentralized, participant-centric design makes it more efficient and cost-effective than standard clinical trials, its investigators say.
- June 13, 2024
Kenneth Zhou, 5th year Immunobiology student, awarded an F31.
- May 24, 2024
Immunobiology Student Awarded the Prize Teaching Fellowship
- May 17, 2024
The Anopheles mosquito species is the primary vector responsible for transmitting malaria, a potentially fatal blood-borne illness. Since previous studies have identified various factors influencing mosquitoes' ability to transmit malaria, Yale researchers in the Department of Internal Medicine’s Section of Infectious Diseases sought to understand the factors affecting the resistance to malaria in mosquitoes lacking the mosGILT protein.
- May 16, 2024Source: TIME
Akiko Iwasaki, an immunobiologist at the Yale University School of Medicine, is working with Michael Tal at MIT to map an immune profile of chronic Lyme, analyzing patients’ blood and saliva samples to search for biological markers that may differentiate people who have long-term symptoms from those who don’t.
- May 15, 2024Source: Medscape
If there's one person you'd want to talk to about immunology, the immune system and COVID, holes in our knowledge base about the complex immune system, and where the field is headed, it would be Professor Iwasaki. And add to that the topic of Women in Science. Here's our wide-ranging conversation.
- May 10, 2024Source: Yale Medicine
This treatment is helping many people’s immune systems outsmart disease. The long-term goal is to make immunotherapy work for everyone.
- May 06, 2024
More than half of human cancers, called “non-inflamed” or “cold” tumors, are not being effectively infiltrated by the cancer-fighting T cells. Essentially, the soldiers are excluded from the battlefield. Yale Cancer Center researchers want to know why.